Diabetes Res Clin Pract

1. WAGNER J, Bermudez-Millan A, Feinn RS
   Health-related social needs and self-Reported health among adults with type 1 diabetes in the 2022 Behavioral Risk Factor Surveillance System.
   Diabetes Res Clin Pract. 2026;231:113077.
   

   >> Share

   
   
2. LAINE MK, Haapala M, Uusi-Rauva K, Aakko J, et al
   Disease management, outcomes, and healthcare resource utilization in real-life clinical practice of diabetes and diabetic kidney disease in Finland.
   Diabetes Res Clin Pract. 2026;231:113067.
   

   >> Share

   
   
3. OZAIRI EA, Taghadom E, Irshad M, Yousef AA, et al
   Combining glucagon-like peptide 1 analogues with sodium-glucose cotransporter 2 inhibitors to treat patients with type 1 diabetes, BMI > 25 kg/m(2), and chronic kidney disease - A randomised, controlled pilot study.
   Diabetes Res Clin Pract. 2026;231:113066.
   

   >> Share

   
   
4. WAGNER R, Fuchtenbusch M, Hummel M, Miszon M, et al
   Adult-onset type 1 diabetes: early detection, differential diagnosis, and emerging disease-modifying therapies.
   Diabetes Res Clin Pract. 2026;231:113047.
   

   >> Share

   
   
5. PAVAN J, Nass R, Fabris C, Fathi AE, et al
   Human factors in the use and efficacy of decision support technologies for type 1 diabetes: evidence from a randomized controlled trial.
   Diabetes Res Clin Pract. 2026;231:113049.
   

   >> Share

   
   
6. PASSANISI S, Piona C, Mancioppi V, Puli L, et al
   Optimal age, duration of diabetes and frequency of screening for diabetic nephropathy in children and youths with type 1 Diabetes: A systematic review.
   Diabetes Res Clin Pract. 2026;231:113042.
   

   >> Share

   
   
7. SOTIRIOU G, Dimitriadou M, Nemtsa A, Kavoura E, et al
   When the summer camp ends: Short-term, post-camp deterioration of glycemic control in youth with type 1 diabetes.
   Diabetes Res Clin Pract. 2026;231:113039.
   

   >> Share

   
   
8. QIN L, Ma W, Cui S, Du Y, et al
   Global burden of type 1 diabetes in adults aged 40-64: trends from 1990 to 2021 and projections to 2036.
   Diabetes Res Clin Pract. 2026;231:113022.
   

   >> Share

   
   
9. GONCALVES S, Coelho C, Pretre L, Roussillon C, et al
   Chat, Gemini and Claude at the dinner table: assessing general-purpose AI tools for carbohydrate counting in the context of type 1 diabetes.
   Diabetes Res Clin Pract. 2026;231:113031.
   

   >> Share

   
   
10. LLAURADO G, Cano A, Gimenez-Palop O, Albert L, et al
    Insulin resistance and abdominal adiposity discriminate early vascular aging (higher vascular risk) in adults with type 1 diabetes without cardiovascular events.
    Diabetes Res Clin Pract. 2026;231:113010.
    

    >> Share

    
    

    
    J Neurol

11. GYGER N, Monschein T, Filser M, Batge S, et al
    Cognitive training, exercise training or combined training? A comparative effectiveness research study on subjective and objective cognitive outcomes in multiple sclerosis.
    J Neurol. 2026;273:82.
    

    >> Share

    
    
12. GRECO G, Della Porta G, Masi F, Redemagni C, et al
    Two-year OCT follow-up in multiple sclerosis patients on Ofatumumab shows retinal preservation over non-antiCD20 treatments.
    J Neurol. 2026;273:77.
    

    >> Share

    
    

    
    N Engl J Med

13. LI R, Pan H, Zhang L, Ma J, et al
    CD19 CAR T-Cell Therapy for Autoimmune Hemolytic Anemia.
    N Engl J Med. 2026;394:253-267.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share